Dr. Salem R. Al Rabadi, MD

Dr. Al Rabadi practices at Abrazo West Campus in Goodyear, Arizona, part of Tenet Healthcare.

Dr. Al Rabadi's NPI, 1104388511, was assigned on April 3, 2019. Dr. Al Rabadi holds Arizona license 65770.

Dr. Al Rabadi's primary practice is Abrazo West Campus, at Sallie, Goodyear, AZ 85395 in Maricopa County. The practice phone is (623) 882-1970. Dr. Al Rabadi also practices at Abrazo West Campus, 13677 W McDowell Rd, Goodyear, AZ 85395.

Dr. Al Rabadi's primary practice is Abrazo West Campus in Goodyear, Arizona, part of Tenet Healthcare. The medical group on file is Sound Physicians. Dmand AI also links Dr. Al Rabadi to 7 more medical groups, 1 group practice or clinic, 1 hospice and 1 skilled nursing facility, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Al Rabadi practices, 4 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Al Rabadi's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Al Rabadi is licensed in Arizona.

CMS data shows 3,469 Medicare services from Dr. Al Rabadi across 9 procedure codes in 2024, for 825 Medicare patients. Medicare paid $300,751 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 825 Medicare patients who saw Dr. Al Rabadi in 2024. The largest group is 75 to 84, with 336 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 20% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Al Rabadi's median patient age at 71, with 51% women.

In 2024, Dr. Al Rabadi wrote 1,693 Medicare Part D claims for 250 patients. 80% of them were for generic drugs. CMS names the drug for 1,215 of them, across 41 drugs with 11 or more claims each, at $44,834 in total drug cost. In 2023, CMS named 967 claims across 37 drugs.

Dr. Al Rabadi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Dr. Al Rabadi from 4 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Edwards Lifesciences Corporation paid the most, $303.